Cite
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation.
MLA
Yegya-Raman, Nikhil, et al. “Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation.” International Journal of Radiation Oncology, Biology, Physics, vol. 118, no. 5, Apr. 2024, pp. 1445–54. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2023.08.039.
APA
Yegya-Raman, N., Friedes, C., Lee, S. H., Iocolano, M., Duan, L., Wang, X., Li, B., Aggarwal, C., Cohen, R. B., Su, W., Doucette, A., Levin, W. P., Cengel, K. A., DiBardino, D., Teo, B.-K. K., O’Reilly, S. E., Sun, L., Bradley, J. D., Xiao, Y., & Langer, C. J. (2024). Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation. International Journal of Radiation Oncology, Biology, Physics, 118(5), 1445–1454. https://doi.org/10.1016/j.ijrobp.2023.08.039
Chicago
Yegya-Raman, Nikhil, Cole Friedes, Sang Ho Lee, Michelle Iocolano, Lian Duan, Xingmei Wang, Bolin Li, et al. 2024. “Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation.” International Journal of Radiation Oncology, Biology, Physics 118 (5): 1445–54. doi:10.1016/j.ijrobp.2023.08.039.